ZIM LABORATORIES
Back to Balance Sheet
|
ZIM LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹53 Cr | ₹49 Cr | ₹30 Cr | ₹20 Cr | ₹19 Cr |
What is the latest Total Non-Current Liabilities ratio of ZIM LABORATORIES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹53 Cr |
Mar2024 | ₹49 Cr |
Mar2023 | ₹30 Cr |
Mar2022 | ₹20 Cr |
Mar2021 | ₹19 Cr |
How is Total Non-Current Liabilities of ZIM LABORATORIES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹53 Cr | 9.80 | |
Mar2024 | ₹49 Cr | 59.79 | |
Mar2023 | ₹30 Cr | 52.16 | |
Mar2022 | ₹20 Cr | 3.12 | |
Mar2021 | ₹19 Cr | - |
Compare Total Non-Current Liabilities of peers of ZIM LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ZIM LABORATORIES | ₹372.6 Cr | -3.5% | -32.6% | -29.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹389,172.0 Cr | 1.8% | -3.6% | -7.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,248.0 Cr | -2.8% | -12.1% | 24% | Stock Analytics | |
CIPLA | ₹122,835.0 Cr | 2.3% | 2.4% | -4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,793.0 Cr | 2.9% | 6.5% | 8.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,869.0 Cr | 2% | -2.4% | -13.1% | Stock Analytics |
ZIM LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ZIM LABORATORIES | -3.5% |
-32.6% |
-29.4% |
SENSEX | -0.6% |
-2.8% |
1.7% |
You may also like the below Video Courses